Acute mesenteric ischemia in SARS CoV 2: A conventional approach

Abstract

SARS CoV 2, a novel coronavirus, an airborne virus has been investigated for its inconspicuous prothrombotic states, the mesenteric vessels are one of the many devoured by the virus. Gastrointestinal symptoms may range from a mild gastroenteritis to a grave ischemia indicating a possibility of a severe infection. The hypercoagulability in SARS Cov -2 is possibly related to the hypercoagulable state attributed by the heightened systemic inflammatory response. The interplay of anticoagulants and the immune response is crucial in the management of critical patients , D dimer a fibrin degradation product has demonstrated efficacy in the surveille of coagulability .This case study involved in the scrutiny of a case with the initial presentation of symptoms of lower respiratory tract infection progressing into gastrointestinal symptoms focusses on the medical management of acute mesenteric ischemia in SARS CoV 2, stressing on the importance of early detection and prompt management of the hypercoagulable condition in systems other than the pulmonary system associated with SARS CoV 2. A meticulous analysis of ischemic states in various other organs should be sought in the pandemic.